XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Unrecognized Gains (Losses) on Derivative Instruments
Pension Obligations
Cumulative Translation Adjustment
Retained Earnings
Non-controlling Interest
Beginning of period at Dec. 31, 2017 $ 445,723 $ 89,755 $ (8,498) $ (5,257) $ (75,366) $ 393,146 $ 51,943
Beginning of the period (in shares) at Dec. 31, 2017   24,917,025          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 18,452         18,452  
Change in unrecognized gains (losses) on derivative instruments, net of tax (4,079)   (4,079)        
Change in employee benefit plans, net of taxes 131     131      
Net foreign currency translation adjustment (14,329)       (14,329)    
Stock options exercised 68 $ 68          
Stock options exercised (in shares)   4,500          
Common stock issued, net of shares withheld for employee taxes (in shares)   90,205          
Stock-based compensation 1,107 $ 1,107          
Cash dividends declared (4,845)         (4,845)  
Redeemable preferred dividend and accretion (16,204)         (16,204)  
Reclassification to European non-controlling redeemable equity (51,943)           (51,943)
Adjust European non-controlling redeemable equity to redemption value (3,625) (3,625)          
European non-controlling redeemable equity dividend (1,084)         (1,084)  
End of period at Jun. 30, 2018 369,372 $ 87,305 (12,577) (5,126) (89,695) 389,465  
End of the period (in shares) at Jun. 30, 2018   25,011,730          
Beginning of period at Dec. 31, 2017 445,723 $ 89,755 (8,498) (5,257) (75,366) 393,146 $ 51,943
Beginning of the period (in shares) at Dec. 31, 2017   24,917,025          
End of period at Dec. 31, 2018 $ 373,265 $ 87,723 (3,205) (3,000) (99,290) 391,037  
End of the period (in shares) at Dec. 31, 2018 25,019,237 25,019,237          
Beginning of period at Mar. 31, 2018 $ 424,280 $ 86,259 5,412 (5,170) (54,462) 392,241  
Beginning of the period (in shares) at Mar. 31, 2018   24,984,791          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,135         8,135  
Change in unrecognized gains (losses) on derivative instruments, net of tax (17,989)   (17,989)        
Change in employee benefit plans, net of taxes 44     44      
Net foreign currency translation adjustment (35,233)       (35,233)    
Stock options exercised 68 $ 68          
Stock options exercised (in shares)   4,500          
Common stock issued, net of shares withheld for employee taxes (in shares)   22,439          
Stock-based compensation 978 $ 978          
Cash dividends declared (2,265)         (2,265)  
Redeemable preferred dividend and accretion (8,135)         (8,135)  
European non-controlling redeemable equity dividend (511)         (511)  
End of period at Jun. 30, 2018 369,372 $ 87,305 (12,577) (5,126) (89,695) 389,465  
End of the period (in shares) at Jun. 30, 2018   25,011,730          
Beginning of period at Dec. 31, 2018 $ 373,265 $ 87,723 (3,205) (3,000) (99,290) 391,037  
Beginning of the period (in shares) at Dec. 31, 2018 25,019,237 25,019,237          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 9,220         9,220  
Change in unrecognized gains (losses) on derivative instruments, net of tax 6,782   6,782        
Change in employee benefit plans, net of taxes 83     83      
Net foreign currency translation adjustment 684       684    
Common stock issued, net of shares withheld for employee taxes (in shares)   95,361          
Stock-based compensation 1,809 $ 1,809          
Cash dividends declared (4,582)         (4,582)  
Redeemable preferred dividend and accretion (15,688)         (15,688)  
European non-controlling redeemable equity dividend (383)         (383)  
End of period at Jun. 30, 2019 $ 371,190 $ 89,532 3,577 (2,917) (98,606) 379,604  
End of the period (in shares) at Jun. 30, 2019 25,114,598 25,114,598          
Beginning of period at Mar. 31, 2019 $ 363,014 $ 88,119 1,721 (2,959) (106,639) 382,772  
Beginning of the period (in shares) at Mar. 31, 2019   25,073,360          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,270         7,270  
Change in unrecognized gains (losses) on derivative instruments, net of tax 1,856   1,856        
Change in employee benefit plans, net of taxes 42     42      
Net foreign currency translation adjustment 8,033       8,033    
Common stock issued, net of shares withheld for employee taxes (in shares)   41,238          
Stock-based compensation 1,413 $ 1,413          
Cash dividends declared (2,259)         (2,259)  
Redeemable preferred dividend and accretion (7,917)         (7,917)  
European non-controlling redeemable equity dividend (262)         (262)  
End of period at Jun. 30, 2019 $ 371,190 $ 89,532 $ 3,577 $ (2,917) $ (98,606) $ 379,604  
End of the period (in shares) at Jun. 30, 2019 25,114,598 25,114,598